News
2d
Pharmaceutical Technology on MSNWeightWatchers shuns compounded semaglutide amid FDA rules
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy ...
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results